Highlights and Quick Summary
- Total Debt for the quarter ending February 28, 2023 was $147 Thousand (a -8.94% decrease compared to previous quarter)
- Year-over-year quarterly Total Debt decreased by -26.61%
- Annual Total Debt for 2022 was $185 Thousand (a -24.42% decrease from previous year)
- Annual Total Debt for 2021 was $245 Thousand (a -99.71% decrease from previous year)
- Annual Total Debt for 2020 was $85.7 Million (a 129.3% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total Debt of Organigram Holdings Inc.
Most recent Total Debtof OGI including historical data for past 10 years.Interactive Chart of Total Debt of Organigram Holdings Inc.
Organigram Holdings Inc. Total Debt for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.15 | – | – | – | – |
| 2022 | $0.16 | $0.18 | $0.2 | $0.21 | $0.18 |
| 2021 | $0.23 | $0.24 | $0.26 | $46.14 | $0.24 |
| 2020 | $87.58 | $85.75 | $61.14 | $64.68 | $85.75 |
| 2019 | $63.92 | $37.4 | $36.9 | $46.74 | $37.4 |
| 2018 | – | – | $75.46 | $77.66 | $77.66 |
| 2017 | – | – | – | – | $2.77 |
| 2016 | – | – | – | – | $5.72 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic